Abstract
Life-threatening pulmonary complications that coincide with cell lysis during early chemotherapy and that mimic systemic inflammatory response syndrome (SIRS) have been reported in patients with acute myeloid leukemia (AML). We reviewed the records of patients with de novo AML, excluding M3 and Down syndrome, treated at our institution between 1991 and 2002 to determine the prevalence of severe SIRS with grade 3/4 pulmonary complications and to identify AML subtypes associated with severe SIRS. To examine the role of cell lysis, we compared leukocyte reduction in AML subtypes affected by severe SIRS with that in unaffected subtypes. Of 155 patients, 5 (3 with M4eo and 2 with M5) experienced severe pulmonary complications attributed to tumor lysis, met the criteria for severe SIRS, and showed no clear evidence of infection. Four required pressor support for severe hypotension. Severe SIRS was significantly more common in myelomonocytic or monocytic AML (M4/M4eo/M5) than in other subtypes (P = 0.010) and significantly more common in M4eo than in M4/M5 (P = 0.008). Among 112 cases for which information was available, leukocyte reduction was significantly greater in patients with M4/M4eo/M5 than among others during the first 4 days...Continue Reading
References
Mar 15, 1992·Cancer·H DombretL Degos
Jan 1, 1984·Medical and Pediatric Oncology·M MarkmanS I Wasserman
May 15, 1983·Cancer·T J MyersD H Hild
Dec 15, 1982·Cancer·A F TrykaC H Fanta
Oct 1, 1996·Computer Methods and Programs in Biomedicine·I KorhonenG Carrault
Jan 23, 1999·The New England Journal of Medicine·A P Wheeler, G R Bernard
Aug 6, 2000·British Journal of Haematology·W A LesterT C Morris
Mar 10, 2001·Paediatric Anaesthesia·E Farley-HillsP Sartori
Mar 27, 2001·Blood·A StuckiO Spertini
Apr 20, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G GattaUNKNOWN EUROCARE Working Group
May 18, 2001·Best Practice & Research. Clinical Haematology·A K Burnett
Aug 23, 2001·Leukemia·B I RazzoukR C Ribeiro
Dec 18, 2001·Medical and Pediatric Oncology·T EkJ Abrahamsson
Mar 21, 2002·Annals of Hematology·T S K WanS K Ma
Jul 30, 2002·Neonatal Network : NN·R Zylberberg, M Pepper
Jul 30, 2002·Neonatal Network : NN·C A Botwinski
Oct 5, 2002·Cancer·Gemma GattaFranco Berrino
Oct 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Kristine R CrewsRaul C Ribeiro
Nov 15, 2002·European Journal of Haematology·M D SeftelT J Nevill
Nov 20, 2002·Journal of Pediatric Hematology/oncology·Kristine R CrewsBassem I Razzouk
Apr 15, 2003·Leukemia & Lymphoma·Fernando Perez-ZincerMatt E Kalaycio
Jul 9, 2003·Journal of Pediatric Hematology/oncology·Jeffrey E SchmidtBassem I Razzouk
Aug 23, 2003·Biostatistics·D Y Lin
Citations
Aug 27, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·H LacknerC Urban
May 13, 2011·The New England Journal of Medicine·Scott C HowardChing-Hon Pui
Sep 14, 2014·International Journal of Hematology·Daisuke SuzukiKunihiko Kobayashi
Jan 23, 2016·Journal of Pediatric Hematology/oncology·Oussama AblaAhmed Naqvi
Jun 30, 2012·Revue des maladies respiratoires·F VincentUNKNOWN Groupe de recherche en réanimation respiratoire en onco-hématologie
May 20, 2008·Cancer·Hiroto InabaBassem I Razzouk
Oct 27, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Denish MikaC Guruvayoorappan
Jul 1, 2015·Case Reports in Hematology·Michael HuangAshok Raj
May 9, 2012·Blood·Jeffrey E Rubnitz
Jun 15, 2018·BMJ Case Reports·Prajwal DhakalMukta Sharma
Nov 20, 2016·Medicine·Michael StefanskiAndry Van de Louw
Jun 18, 2017·Cancer·Naval DaverHagop M Kantarjian
Sep 11, 2019·Pediatric Blood & Cancer·Lane H MillerWilliam G Woods
Dec 16, 2020·Hematology·Lu-Hong XuFeng-Ying Yang
Nov 25, 2020·Pediatric Clinics of North America·Lama ElbahlawanRaul C Ribeiro
Jul 14, 2021·Cancer Reports·Motohiro MatsuiYuki Yuza